Royal Bank of Canada’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-27,621
| Closed | -$184K | – | 7162 |
|
|
2023
Q3 | $184K | Buy |
27,621
+11,163
| +68% | +$74.4K | ﹤0.01% | 4411 |
|
|
2023
Q2 | $150K | Buy |
16,458
+4,554
| +38% | +$41.5K | ﹤0.01% | 4572 |
|
|
2023
Q1 | $86K | Sell |
11,904
-15,063
| -56% | -$109K | ﹤0.01% | 4921 |
|
|
2022
Q4 | $196K | Sell |
26,967
-220,135
| -89% | -$1.6M | ﹤0.01% | 4452 |
|
|
2022
Q3 | $1.91M | Buy |
247,102
+514
| +0.2% | +$3.97K | ﹤0.01% | 2513 |
|
|
2022
Q2 | $1.68M | Sell |
246,588
-302,871
| -55% | -$2.06M | ﹤0.01% | 2682 |
|
|
2022
Q1 | $4.38M | Buy |
549,459
+545,356
| +13,292% | +$4.35M | ﹤0.01% | 2053 |
|
|
2021
Q4 | $23K | Buy |
4,103
+1,103
| +37% | +$6.18K | ﹤0.01% | 6215 |
|
|
2021
Q3 | $23K | Buy |
+3,000
| New | +$23K | ﹤0.01% | 6121 |
|